SCHEMBL16014103

SCHEMBL16014103

N#Cc1c(-c2ccccc2F)nc2c(c1N)CCCC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.52
ADORA1 P30542 3/20 0.52
KDM4E B2RXH2 8/20 0.48
HSD17B10 Q99714 5/20 0.48
ACHE P22303 5/20 0.48
ALDH1A1 P00352 6/20 0.47
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
CUL4A Q13619 1/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 2/20 0.44
THRB P10828 2/20 0.44
ADORA2B P29275 2/20 0.43
BCHE P06276 4/20 0.43
TSHR P16473 2/20 0.43
CACNB4 O00305 1/20 0.43
CACNA1A O00555 1/20 0.43
SLC22A2 O15244 1/20 0.43
SLC22A1 O15245 1/20 0.43
ABCC4 O15439 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16014105 0.80 KDM4E (0.68) ADORA2AKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL6072767 0.73 ADORA2A (0.60) ADORA2AADORA1KDM4EHSD17B10ACHE
SCHEMBL5138971 0.68 PIP4K2A (0.58) ADORA2AADORA1KDM4EALDH1A1HPGD
SCHEMBL6254905 0.68 KDM4E (0.70) ADORA2AKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL22021219 0.68 ACHE (0.46) KDM4EHSD17B10ACHEALDH1A1SMN1; SMN2
SCHEMBL30162064 0.68 ACHE (0.46) KDM4EHSD17B10ACHEALDH1A1SMN1; SMN2
SCHEMBL6440793 0.67 XDH (0.66) ADORA2AADORA1KDM4EALDH1A1HPGD
SCHEMBL17351623 0.66 ALDH1A1 (0.52) ADORA2AKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL23207157 0.66 HTR7 (0.42) ADORA2AADORA1KDM4EACHEALDH1A1
SCHEMBL9259795 0.66 GABRA3 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964644-A1 PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE Amgen Inc. (US) 2016-01-13 EP disclosed
WO-2014138484-A1 PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE AMGEN INC. (US) 2014-09-12 WO disclosed